XYL Share Price | Xylem, Inc. Stock Analysis & Recommendation

Q: How big is Xylem, Inc.?

Market Cap: As of Jun 18, Xylem, Inc. has a market capitalization of 32,414.54 million, categorizing it as a Large Cap company.Recent Quarterly Performance: For the latest four quarters, Xylem, Inc. reported net sales of 8,596.00 million and a net profit of 904.00 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 10,642.00 million and total assets of 16,493.00 million.

Q: What does Xylem, Inc. do?

Overview:Xylem, Inc. is a water technology company operating in the industrial manufacturing sector, focusing on engineered solutions for water and wastewater applications.Financial Snapshot:Most recent Net Sales: 2,066 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 167 Million (Quarterly Results - Mar 2025) Market cap: USD 32,414.54 Million (Large Cap) Key Metrics:P/E: 35.00 Dividend Yield: 112.93% Debt Equity: 0.10 Return on Equity: 8.64% Price to Book: 3.00 Contact Details:Address: 1 International Dr, RYE BROOK NY: 10573 Tel: ['1 914 3235700', '1 914 3235821'] Fax: 1 914 3235800 Website: https://www.xylem.com/

Q: Is Xylem, Inc. technically bullish or bearish?

As of 26 September 2025, the technical trend for Xylem, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators: both weekly and monthly MACD are bullish, Bollinger Bands are bullish across both time frames, and daily moving averages are also bullish. The KST shows a bullish weekly trend but is mildly bearish monthly, while Dow Theory indicates a mildly bullish stance on both weekly and monthly bases. Despite the bullish outlook, the OBV is mildly bearish on a weekly basis. In terms of performance, Xylem has outperformed the S&P 500 year-to-date with a return of 23.28% compared to the S&P 500's 12.96%, but it has lagged over longer periods, such as the 3-year and 5-year returns.

Q: Is Xylem, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a significantly higher P/E of 52.55, while Dover Corp. is at 43.35, suggesting that Xylem's valuation is not as extreme as some competitors but still elevated.Despite a strong year-to-date return of 29.02% compared to the S&P 500's 16.30%, Xylem's longer-term performance has lagged behind, with a 5-year return of 63.40% versus the S&P 500's 109.18%. This discrepancy reinforces the notion that while Xylem has performed well recently, its current valuation may not be justified given its relative performance and the valuation metrics compared to its peers.

Results Declared: Xylem, Inc. has declared results on 28 Apr 2026! Click here to unlock the latest financial performance

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

488.91 k

Shareholding (Mar 2026)

FII

36.91%

Held by 477 FIIs

DII

33.72%

Held by 56 DIIs

Promoter

0.00%

How big is Xylem, Inc.?

22-Jun-2025

As of Jun 18, Xylem, Inc. has a market capitalization of $32.41 billion, with recent net sales of $8.60 billion and a net profit of $904 million over the last four quarters.

View full answer

What does Xylem, Inc. do?

22-Jun-2025

Xylem, Inc. is a water technology company specializing in engineered solutions for water and wastewater applications, with recent net sales of $2.066 billion and a market cap of $32.41 billion. Key metrics include a P/E ratio of 35.00 and a dividend yield of 112.93%.

View full answer

Who are in the management team of Xylem, Inc.?

22-Jun-2025

As of March 2022, the management team of Xylem, Inc. includes Markos Tambakeras (Independent Chairman), Patrick Decker (CEO), and several independent directors: Jeanne Beliveau-Dunn, Curtis Crawford, Robert Friel, Jorge Gomez, and Victoria Harker. They oversee the company's strategic direction and operations.

View full answer

Is Xylem, Inc. technically bullish or bearish?

29-Sep-2025

As of September 26, 2025, Xylem, Inc. has a bullish technical trend with strong indicators, outperforming the S&P 500 year-to-date with a 23.28% return, although it has lagged in longer-term performance.

View full answer

Is Xylem, Inc. overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Xylem, Inc. is considered expensive with a P/E ratio of 35 and other elevated metrics, despite a strong recent return of 29.02%, as its longer-term performance lags behind the S&P 500.

View full answer

Compare Xylem, Inc. with Similar Stocks

Ingersoll Rand, Inc.Johnson Controls International Plc Trane Technologies Plc

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Company has a low Debt to Equity ratio (avg) at times

Low Debt Company with Strong Long Term Fundamental Strength

The company has declared Positive results for the last 7 consecutive quarters

With ROCE of 9.26%, it has a expensive valuation with a 2.84 Enterprise value to Capital Employed

Mojo Parameters

Stock DNA

Industry

Industrial Manufacturing

Market cap

USD 31,277 Million (Mid Cap)

P/E

32.00

Industry P/E

Dividend Yield

125.51%

Debt Equity

0.04

Return on Equity

8.53%

Price to Book

2.72

Revenue and Profits:

Net Sales:

2,122 Million

(Quarterly Results - Mar 2026)

Net Profit:

189 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-16.41%

6 Months

-22.76%

1 Year

-4.86%

2 Years

-15.17%

3 Years

6.81%

4 Years

34.9%

5 Years

-0.83%

Xylem, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

13.14%

EBIT Growth (5y)

43.81%

EBIT to Interest (avg)

9.14

Debt to EBITDA (avg)

1.27

Net Debt to Equity (avg)

0.10

Sales to Capital Employed (avg)

0.64

Tax Ratio

18.41%

Dividend Payout Ratio

40.82%

Pledged Shares

Institutional Holding

94.40%

ROCE (avg)

11.32%

ROE (avg)

11.08%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.72

EV to EBIT

9.96

EV to EBITDA

8.44

EV to Capital Employed

2.66

EV to Sales

3.51

PEG Ratio

4.66

Dividend Yield

125.51%

ROCE (Latest)

26.68%

ROE (Latest)

8.53%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 154 Schemes (29.34%)

Foreign Institutions

Held by 477 Foreign Institutions (36.91%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -11.25% vs 5.56% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -43.24% vs 47.35% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,122.00",
          "val2": "2,391.00",
          "chgp": "-11.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "410.00",
          "val2": "522.00",
          "chgp": "-21.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.00",
          "val2": "17.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.00",
          "val2": "-22.00",
          "chgp": "18.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "189.00",
          "val2": "333.00",
          "chgp": "-43.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "127.20%",
          "val2": "158.50%",
          "chgp": "-3.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.47% vs 16.23% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.74% vs 46.14% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,031.00",
          "val2": "8,563.00",
          "chgp": "5.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,892.00",
          "val2": "1,635.00",
          "chgp": "15.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "71.00",
          "val2": "76.00",
          "chgp": "-6.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-61.00",
          "val2": "-30.00",
          "chgp": "-103.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "950.00",
          "val2": "890.00",
          "chgp": "6.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "145.80%",
          "val2": "125.30%",
          "chgp": "2.05%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,122.00

2,391.00

-11.25%

Operating Profit (PBDIT) excl Other Income

410.00

522.00

-21.46%

Interest

17.00

Exceptional Items

-18.00

-22.00

18.18%

Consolidate Net Profit

189.00

333.00

-43.24%

Operating Profit Margin (Excl OI)

127.20%

158.50%

-3.13%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -11.25% vs 5.56% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -43.24% vs 47.35% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

9,031.00

8,563.00

5.47%

Operating Profit (PBDIT) excl Other Income

1,892.00

1,635.00

15.72%

Interest

71.00

76.00

-6.58%

Exceptional Items

-61.00

-30.00

-103.33%

Consolidate Net Profit

950.00

890.00

6.74%

Operating Profit Margin (Excl OI)

145.80%

125.30%

2.05%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 5.47% vs 16.23% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 6.74% vs 46.14% in Dec 2024

All Annual Results

Company CV

About Xylem, Inc.

Xylem, Inc.

Industrial Manufacturing

Xylem Inc. is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment. It has three business segments, which include Water Infrastructure, Applied Water and Sensus. Water Infrastructure focuses on the transportation, treatment and testing of water, offering a range of products, including water and wastewater pumps, and controls and systems. Applied Water serves the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Sensus segment's products include metering, networked communications, measurement and control technologies, software and services, including cloud-based analytics, remote monitoring and data management.

Company Coordinates

Company Details

1 International Dr , RYE BROOK NY : 10573

Tel: 1 914 32357001 914 3235821

https://www.xylem.com/

Registrar Details